Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from the pharma industry involved in:
15th Annual Patient Recruitment And Retention Summit
22 – 23 February 2023 | Courtyard Berlin City Center
PAST SPEAKERS
SEE THE PREVIOUS SPEAKERS & CASE STUDIES
Andrea Forgione
Global Patient Engagement Manager
Karim Benlahcen
Director, Clinical Operations Neurology & Rare Diseases
Eva Bretschneider
Head of Patient
Partnership & Stakeholder Engagement
Sujoy Chowdhury
Senior Director, Trial Management, International Operations
Caroline Averius
Senior Global Patient Partnership Director
CONFERENCE TOPICS 2023
LOOK AT THE TOPICS THAT WERE DISCUSSED
- Upcoming Novelty in Clinical Trials: Patient Recruitment and Retention
- Patient Recruitment: New Channels for Achieving Goals
- Uncut Diamond – Retention for Keeping Patients Enrolled
- One Size Does Not Fit All: Breaking Recruitment and Retention Barriers
- Embedding Diversity in Clinical Trials: Proactive Approach from Planning to Real Result
- Patient Experience Overlook: An Underrated Ingredient
- Optimising Patient Recruitment and Engagement Strategies: Reduce Risk and Meet Deadlines to Achieve Success
- Tech Side of the Issue: Leveraging Technology and Protecting Data
Designed for
- Patient Recruitment
- Patient Retention
- Clinical Trials
- Clinical Study
- Clinical Operations
- Patient Centricity
- Recruitment Programmes
- Patient Engagement
- Site & Patient Access
- Trials Transparency
- Feasibility & Recruitment
- Monitoring Operations
- Clinical Development
- Clinical Research
- Study Management
- Clinical Research & Development
- Clinical Trial Operations
- Patient Recruitment and Retention
- Clinical Site Management
- Global Study Programmes
- Clinical Program Management
- Study Start-Up Unit
CASE STUDY
Patient Real World Insights: The “Last Mile” of Knowledge to Improve Clinical Outcomes
A misalignment of language, culture, perception, and/or late Pharma knowledge of patients’ experiences, can have an impact on clinical outcome. Environment, Digital Health Transformation, and Decision Makers are shaping ‘Modern Patient’ as an increasingly central and dynamic health consumer. It is time to learn what really happens in the last mile of patients’ real life.
- Patient’s voice and experience into every stage of the Patient Journey
- Rethinking the “view” of a patient by building a holistic, 360-degree patient profile
- Benefits of adopting a Unified Patient Experience
Andrea Forgione
Global Patient Engagement Manager
Menarini Group
Eva Bretschneider
Head of Patient Partnership & Stakeholder Engagement
Bayer
CASE STUDY
Patient Partnership Enhancing Diversity in Clinical Trials
Case study on how Bayer’s patient engagement plan enhanced diversity and representation in our clinical trials. How Bayer partners to co-create and co-develop solutions with patient advocacy groups and Standing Councils so outreach approach and recruitment materials resonate with the community.
How Bayer partners with patients to enhance diversity in clinical trials:
- Diversity plan to facilitate recruitment and study experience
- Developing a diversity plan to be submitted to regulators
- Drafting diversity plan blueprint
CASE STUDY
Optimizing Patient Recruitment and Engagement Strategies
Understanding clinical trial participation from the patient’s perspective is something crucial. Before Clinical trial implementation, it is important to hear from Patients Advocacy Groups (PAGs) what the patient’s experience is with a similar trial design and the therapeutic indication specificities. This will help optimise the strategy: right patients at the right sites
• What does it mean to be patient in a Clinical Trial
• Why does the patient accept to participate in a Clinical Trial
• Enhancing patient recruitment and retention using the right communication tools
• Role of new technologies and who could benefit from
Karim Benlahcen
Director, Clinical Operations Neurology & Rare Diseases
Sanofi
Caroline Averius
Senior Global Patient Partnership Director
Roche
CASE STUDY
The community voice: why science desperately needs co-created clinical trials
At Roche, our mission is to do now what patients need next. To enable this, our Global Patient Partnership team works to embed key community perspectives and insights into core decision-making across the company. One focus area is to maintain strong and sustainable partnerships with communities to achieve people-relevant R&D and solutions. Through this collaboration we can improve clinical trial design and outcomes to develop meaningful solutions focused on participant benefits. This recently led to the development of a series of Clinical Trials guidebooks across different therapy areas within neuroscience. These co-created materials with community representatives provide considerations for those designing or conducting clinical trials to make them more participant-friendly and have been built directly with representatives of the communities the research serves. Our Autism and Alzheimer’s guidebooks will be made publicly available in October this year, and we hope that these tools ultimately pave the way for more successful research and trials which put the participant first.
Sponsors
STAY UPDATED FOR THE 2024 EDITION
Provide Us With Your Contact Details and Our Team Will Get Back to You With All the Updates Regarding the Upcoming Edition of This Event.
